Clear enough -- thank you!
-----Original Message-----
From: Research Administration List on behalf of Erin C Davis
Sent: Mon 4/6/2009 6:13 AM
To: xxxxxx@hrinet.org
Subject: Re: [RESADM-L] Page limits on NIH Recovery Act Competition C06
Here is the answer I received from NRCC:
How many pages can the application be?
The entire project narrative can be no more than 20 pages. This includes
all sections. The Significance& Need section as well as the Project
Management section ARE included in the 20 page limit. The tables and line
drawings do not count toward the 20 page limit.
To be clear, the 20 page limit includes specific aims, background, and all
of the parts of the improvement plan including significance and need,
project management, design considerations, equipment, and the project
timeline.
ERIN C. DAVIS
Grants Development Specialist II
Office of Research Guidance, E-275
Wadsworth Center, NYS DOH
Empire State Plaza
P.O. Box 509
Loading Dock J (use in lieu of PO Box when sending via courier)
Albany, NY 12201-0509
(518) 474-6602 (phone)
(518) 402-5540 (fax)
Stuart Ross
<xxxxxx@CALIT2.U
CI.EDU> To
Sent by: Research xxxxxx@hrinet.org
Administration cc
List
<xxxxxx@hrinet. Subject
org> [RESADM-L] Page limits on NIH
Recovery Act Competition C06
04/03/2009 05:57
PM
Please respond to
Research
Administration
Discussion List
<xxxxxx@hrinet.
org>
I'm having trouble interpreting the requirements of the C06 announcement.
Does the 20-page limit apply to all of Specific Aims, Background,
Improvement Plans, Significance & Need, Project Management, Design
Considerations, Equipment, and Project Timeline?
The heading for "Improvement Plans" seems to be equal with the other
headings and seems to allow 18 pages for itself, but other parts of the
document suggest that all the parts above are in the 20-page limit and that
the whole document, all parts, cannot exceed 40 pages.
Stuart Ross
UC Irvine
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available via
our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================
IMPORTANT NOTICE: This e-mail and any attachments may contain confidential or sensitive information which is, or may be, legally privileged or otherwise protected by law from further disclosure. It is intended only for the addressee. If you received this in error or from someone who was not authorized to send it to you, please do not distribute, copy or use it or any attachments. Please notify the sender immediately by reply e-mail and delete this from your system. Thank you for your cooperation.
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================